Plan ahead
Plan ahead of these events, and schedule time with us!
We can help you:
Understand
Understand the landscape in seconds for the targeted therapy of your choice.
Book a demo
To book a live demo to show you how this works specifically to your questions.
Events Beacon will be attending
3rd Cell Therapy Analytical Development Summit Europe
September 3 – 5, 2024 | London, UK
With regulatory bottlenecks significantly delaying the process of characterisation to method validation and release, the European cell therapy community is actively seeking a central hub to collaborate, connect and share insights to drive the future development of cell therapies forward.
Returning to London this September, the 3rd Cell Therapy Analytical Development Summit Europe is the definitive summit dedicated to defining and refining analytics to ensure the swift progression of highly efficacious products through IND/IMPD and clinical trials.
Uniting pioneering analytical development and quality control experts from Achilles Therapeutics, Avobis Bio, Bristol Myers Squibb, Johnson & Johnson, GSK, and MHRA, this summit is your one-stop shop to spearhead the future of analytical innovation.
Discover the full 3-day agenda details here.
15th World Bispecific Summit 2024
September 3 – 5, 2024 | Boston, MA
The 15th World Bispecific Summit has established itself as the key biopharma-directed event to gain clear insights into the latest advancements and future directions amongst the mass of bispecific antibodies currently being developed and how to address associated development challenges encountered within this therapeutic modality.
If your research teams are looking to keep ahead of the next wave of bispecific antibodies currently in development, join this event to learn how experts are leveraging pioneering new formats like bispecific ADCs and exciting targets like peptide-HLA complexes whilst managing developability and risk.
Presenting ‘A Review of the Bispecific Landscape: The Past, The Present & The Future of Biologics’ our Research Analyst, Flavio Lima Bianchi will be reviewing drug and trial landscapes, discussing the emerging trends in the space, and looking towards the future of the bispecific industry.
Discover the 3-day agenda and Flavio’s talk in more detail here.
ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit 2024
September 9 – 10, 2024 | Boston, MA
Major moves in the pharma and biotech partnering are reshaping the landscape. With AbbVie’s acquisition of ImmunoGen leading the charge in 2023, and Merck’s licensing deal with Daiichi reaching unprecedented heights across three ADC programs, the market frenzy surrounding ADCs has never been hotter.
How does one differentiate and obtain assets poised for clinical success in the next wave of deals?
Enter the ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit. This event cuts through the noise of partnership events to gather a targeted critical mass of 100+ ADC companies.
It provides a platform for networking and fast-tracking the search and evaluation of earlier development assets. By significantly improving the alignment, efficiency, and yield of conversations, this summit empowers participants to navigate the complex partnering landscape with confidence.
Beacon is set to join the expert speaker faculty, to deliver an analysis of clinical data and deals & company landscape across the ADCs & Radiopharmaceuticals market; with more data shared than ever before, this is not one to be missed! Find out more about our talk here.
Find out More
9th CAR-TCR Summit 2024
September 17 – 20, 2024 | Boston, MA
The 9th CAR-TCR Summit remains the industry’s most comprehensive forum to advance end-to-end cell therapy development. You can learn about a variety of cell types for both oncology and autoimmunity, spanning all stages of development. With dedicated tracks and bonus days, you can curate the meeting agenda to meet your specific needs, no matter what your 2024 focus is!
This is your one-stop shop to advance and accelerate the development of safe, effective, and accessible cell therapies by uncovering cutting-edge advances, clinical progression, manufacturing innovations, and operational excellence whilst making connections across the wider community.
Rachel East, Senior Research Analyst, is joining 1,000+ industry colleagues, to provide the latest insights into CAR & TCR therapies during the Translation Track on Day 1! Download the brochure today to find out further details.
2nd Cell Therapy for Autoimmune Disease Summit
December 2-4, 2024 | Philadelphia, PA
Accelerate the Clinical Development of CAR-T, Treg & NK-Based Therapies with Improved Efficacy, Durability & Safety to Revolutionize Curative Care for Chronic Autoimmune Disease.
The Cell Therapy for Autoimmune Disease Summit is an unparalleled, pioneering event that unites leading experts and stakeholders in this exciting emerging field. This groundbreaking summit is a platform for sharing and discussing the latest advances in pre-clinical, translational, and clinical development across various cell types including CAR-T, Tregs, and NKs.
With 75+ attendees, 30+ world-class speakers including the likes of Cabaletta, Cartesian, Abata, and Bristol Myers Squibb delving into everything from new pre-clinical and clinical data, developing therapies with a high safety profile, innovative trial design, translational biomarkers, and over 6 hours of dedicated networking, ensure you join us to revolutionize the treatment landscape for chronic autoimmune diseases.
Our Cell Therapy Research Lead, Rachel Hourigan, joins the line-up, setting the scene, with a comprehensive review of the past, present & future of the cell therapy autoimmune landscape, at 9:00 a.m. Find out more of her session details here; this is one not to be missed!
Find out more
